Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.
about
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future PerspectivesAssessment of Venous Thrombosis in Animal ModelsCardiovascular magnetic resonance imaging for assessment of cardiac thrombusA synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis.Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.Deep vein thrombosis: current status and nanotechnology advances.An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions.Molecular imaging of inflammation in atherosclerosis.Cardiovascular molecular imaging: focus on clinical translationRadiolabelled probes for imaging of atherosclerotic plaques.Blood Accessibility to Fibrin in Venous Thrombosis is Thrombus Age-Dependent and Predicts Fibrinolytic Efficacy: An In Vivo Fibrin Molecular Imaging Study.MR imaging probes: design and applications.Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis.High-relaxivity magnetic resonance imaging contrast agents. Part 2. Optimization of inner- and second-sphere relaxivityActivation and retention: a magnetic resonance probe for the detection of acute thrombosis.Molecular MRI of intracranial thrombus in a rat ischemic stroke model.In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe.The role of molecular imaging in diagnosis of deep vein thrombosisFibrin specific peptides derived by phage display: characterization of peptides and conjugates for imagingStructure - relaxivity relationships among targeted MR contrast agents.Quantitative cardiovascular magnetic resonance for molecular imaging.Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis.Effect of Chelate Type and Radioisotope on the Imaging Efficacy of 4 Fibrin-Specific PET ProbesMolecular MRI of Thrombosis.Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo.The importance of water exchange rates in the design of responsive agents for MRI.Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat modelImaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imagingHeteroditopic binding of magnetic resonance contrast agents for increased relaxivity.Efficient Identification of Murine M2 Macrophage Peptide Targeting Ligands by Phage Display and Next-Generation SequencingStrategies for the preparation of bifunctional gadolinium(III) chelators.Synthetic Strategies for Engineering Intravenous Hemostats.Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in RatsMolecular imaging of atherosclerosis for improving diagnostic and therapeutic developmentDetection of thrombus size and protein content by ex vivo magnetization transfer and diffusion weighted MRITargeted delivery of gold nanoparticle contrast agents for reporting gene detection by magnetic resonance imagingMultimodal Molecular Imaging Reveals High Target Uptake and Specificity of 111In- and 68Ga-Labeled Fibrin-Binding Probes for Thrombus Detection in RatsA Manganese Alternative to Gadolinium for MRI Contrast.Fibrin-targeted PET probes for the detection of thrombi.
P2860
Q26774810-86A6F14A-EDF5-4ED3-9C3C-E0658ED1A457Q26774967-BAA5A881-C696-4FBA-9EA7-33E29AC693FDQ26860052-0E8AD400-7E99-456B-B783-37A8D8D2A96DQ27327667-572CB9FC-3F47-49E9-B69F-F9B5C286D804Q28070313-4AFD2DB0-7929-4F99-8E28-6499060A4CF8Q30369732-18836857-378C-455D-8ACF-C37FAEA404D3Q30425444-8FC6DD8E-B5AF-4E17-BF5E-6492B35DF459Q30446268-176EA1E6-77D2-4D78-B9B5-5CEBA2544D63Q30470859-285F23A9-F83F-4A49-9762-832AB61B2945Q30577193-BB45D563-F7A5-457D-A113-2F7969CFEBEFQ30670224-BB4B4873-149B-47E0-B6BA-369D3FA95153Q30868199-AF15272F-9423-4A0F-BF5D-38BA4F8DE59EQ33631115-6BA37861-85D5-401E-920F-8D9CE35ABE44Q33679680-9FCD6D79-F8AE-451F-B412-E1BAE124B39EQ33697883-A7ABE903-B6AC-4063-AB25-37454E251C95Q33875934-1B2ADA3E-3DB9-4190-85BF-AC39DCB9B13BQ33916932-C30E605C-96AC-4FCE-800A-8712C344B60DQ34066512-98E5966E-C4F6-4F70-84A7-6204676AA71AQ34134243-F49BB748-739A-4479-97F6-79B04EF97A8DQ34320982-20F2400D-51BB-4912-811F-7763CAA0A947Q34330885-506E084C-F0E5-4C34-BBE3-BCA13F87928EQ34333548-80D32A38-A0C2-46D6-963D-86EF5449FABDQ34437799-70B4D4AA-1204-41FD-BB79-47BFAE629299Q34497634-24C75633-69B4-4F68-B8A4-BFB40EDABCFBQ34505823-9A81CD78-6B2F-4A91-893A-2D2AEAB581D7Q34554929-488CE2EF-B18C-40D7-A476-E872390CF1F5Q34591066-DCA3B294-CAC9-48E2-9048-23BE0ADF8141Q35072987-A4B909C2-2C6B-47E5-9EB6-AB82761245DDQ35249665-07E90A7D-DA28-4594-A452-7F829763CF88Q35688211-F5FF926E-2538-4B76-96E9-A1A1C2991667Q35777941-D67C8CAE-1DFE-43E7-AF23-C68CB478F0ACQ35858739-EFB4C9C0-BCFB-4BC0-9E76-A6BC89CC9E25Q36036217-E6783474-4221-4CF8-B682-F05A87444B81Q36093873-C3BFFFDB-8009-4FE6-91AC-784D04CC208AQ36141999-D251638B-0A5C-4C86-AE19-0447F5D60AC8Q36164201-F4596168-2D61-4972-9ADC-F2CA85F49197Q36372692-AAD7A94F-5346-40BF-ADC3-1008E2F063B7Q36604529-AEB5F216-8C0D-49E5-81A3-4ACD38225658Q36609886-96E57E8B-ABAF-4722-A9F8-557EA6D34A4DQ36673486-5B13B956-3F51-4FFA-867E-5C4E139A909B
P2860
Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Thrombus imaging with fibrin-s ...... clinical study of feasibility.
@en
Thrombus imaging with fibrin-s ...... clinical study of feasibility.
@nl
type
label
Thrombus imaging with fibrin-s ...... clinical study of feasibility.
@en
Thrombus imaging with fibrin-s ...... clinical study of feasibility.
@nl
prefLabel
Thrombus imaging with fibrin-s ...... clinical study of feasibility.
@en
Thrombus imaging with fibrin-s ...... clinical study of feasibility.
@nl
P2093
P1476
Thrombus imaging with fibrin-s ...... clinical study of feasibility.
@en
P2093
Andrea J Wiethoff
Edward C Parsons
Elmar Spuentrup
Gerardo Cardenas-Molina
Josef Vymazal
Michael G Hartmann
P304
P356
10.1097/RLI.0B013E3181B092A7
P577
2009-11-01T00:00:00Z